文献速递肝病消化道肿瘤与早癌

靶向腺苷酸琥珀酸裂解酶缺失抑制肝癌生长并损害线粒体功能

Targeting the De Novo Purine Synthesis Pathway Through Adenylosuccinate Lyase Depletion Impairs Liver Cancer Growth by Perturbing Mitochondrial Function.
PubMed 文献 · Hepatology · 2021-07-12

研究通过靶向约2000个可成药基因的CRISPR文库筛选,鉴定出嘌呤从头合成关键酶ADSL为肝癌潜在药靶。ADSL敲除通过影响AMP产生损害集落形成,并在体内延缓肝肿瘤生长,机制为S期阻滞而非DNA损伤,与线粒体功能受损相关。HCC患者中ADSL高表达与肿瘤发生及较差生存率相关。

要点

  • CRISPR文库筛选鉴定ADSL为肝癌潜在药靶
  • ADSL敲除通过损害线粒体功能导致S期阻滞
  • ADSL高表达与HCC发生及较差生存率相关

核心结论

  • ADSL介导的嘌呤从头合成通过支持线粒体ATP产生促进肝癌细胞生长,靶向ADSL可能是HCC治疗策略。

研究设计与样本

  • 使用靶向约2000个可成药基因的CRISPR文库进行高通量筛选,鉴定ADSL为肝癌潜在药靶。

主要发现

  • CRISPR介导的ADSL敲除通过影响AMP产生损害肝癌细胞集落形成。
  • ADSL缺失在体内延缓肝肿瘤生长。
  • ADSL敲除导致S期细胞周期阻滞,并非通过诱导DNA损伤,而是通过损害线粒体功能。
  • HCC患者数据揭示ADSL高表达发生于肿瘤发生过程中,并与较差生存率相关。

临床怎么用

  • 靶向ADSL可能成为HCC患者的治疗方向,但尚需临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is among the most common cancer types worldwide, yet patients with HCC have limited treatment options. There is an urgent need to identify drug targets that specifically inhibit the growth of HCC cells. APPROACH AND RESULTS: We used a CRISPR library targeting ~2,000 druggable genes to perform a high-throughput screen and identified adenylosuccinate lyase (ADSL), a key enzyme involved in the de novo purine synthesis pathway, as a potential drug target for HCC. ADSL has been implicated as a potential oncogenic driver in some cancers, but its role in liver cancer progression remains unknown. CRISPR-mediated knockout of ADSL impaired colony formation of liver cancer cells by affecting AMP production. In the absence of ADSL, the growth of liver tumors is retarded in vivo. Mechanistically, we found that ADSL knockout caused S-phase cell cycle arrest not by inducing DNA damage but by impairing mitochondrial function. Using data from patients with HCC, we also revealed that high ADSL expression occurs during tumorigenesis and is linked to poor survival rate. CONCLUSIONS: Our findings uncover the role of ADSL-mediated de novo purine synthesis in fueling mitochondrial ATP production to promote liver cancer cell growth. Targeting ADSL may be a therapeutic approach for patients with HCC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Jiang T, Sánchez-Rivera FJ, Soto-Feliciano YM, et al. Targeting the De Novo Purine Synthesis Pathway Through Adenylosuccinate Lyase Depletion Impairs Liver Cancer Growth by Perturbing Mitochondrial Function. Hepatology. 2021. PMID: 33336367. doi:10.1002/hep.31685

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。